The Use of Arnica Montana in the Cicatrization of the Umbilical Cord
NCT ID: NCT05958251
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
326 participants
OBSERVATIONAL
2022-05-30
2022-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The complications related to poor hygiene of the umbilical stump can be more or less serious. Mild complications include wet stumps, purulent secretions, granulomas, or periumbilical erythema. The most serious complications involve infections of the umbilical cord stump which can manifest locally or systemically, causing respectively omphalitis or neonatal sepsis. Despite the numerous benefits that derive from proper umbilical cord care, the most suitable approach remains controversial and several modalities of care have been described.
The World Health Organization suggests two techniques depending on the neonatal mortality rate. In developed countries the use of dry cord care is recommended while in countries with a high neonatal mortality rate (\>30 deaths/1000 live births) the topical application of antiseptics, such as chlorhexidine, is recommended. Recent studies have focused on the possible advantages of using natural products of plant origin, whose natural anti-inflammatory and dermal protective action is known. Among them, the anti-inflammatory, antibacterial and immunomodulatory properties of arnica montana have been studied and it has been shown that the use of a powder containing this plant extract reduces parental stress and drop time of the umbilical cord stump. However, there is little evidence demonstrating the lower rate of mild to moderate complications resulting from umbilical cord stump care with this product.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Silver Nitrate Versus Topical Steroid For Umbilical Granuloma
NCT06363539
A Research Study Looking at Specific Tissue of the Umbilical Cord
NCT01166776
The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications
NCT03136159
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
NCT06929572
Umblical Incision for Neonatal Surgery
NCT03256669
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cicaben
Umbilical cord stump of the newborns was medicated by Cicaben ® (Orsana S.r.l.), a natural topical dermo-protective powder
Cicaben
Cicaben® powder is an association of special active ingredients for topical dermatological use with a healing, soothing and protective action (zinc oxide, magnesium oxide, corn starch, arnica montana extract, allantoin and undecylenic acid, arginine, glycine and proline, niacinamide).
Standard dry care
Umbilical cord stump of the newborns was medicated by standard dry care
Standard Care (in control arm)
Standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cicaben
Cicaben® powder is an association of special active ingredients for topical dermatological use with a healing, soothing and protective action (zinc oxide, magnesium oxide, corn starch, arnica montana extract, allantoin and undecylenic acid, arginine, glycine and proline, niacinamide).
Standard Care (in control arm)
Standard care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
35 Weeks
42 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Buon Consiglio Fatebenefratelli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giuseppe De Bernardo
Head of Department of Woman and Child
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giuseppe De Bernardo, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale Buon Consiglio Fatebenefratelli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vittore Buzzi Children's Hospital, ASST-FBF-Sacco
Milan, Milan, Italy
Ospedale Buon Consiglio Fatebenefratelli
Naples, Naples, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
496/CE Lazio 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.